Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 38.66M $38.27M March 31, 2015
Capital Research Global Investors^ 19.49M $2.43B March 31, 2015
Sands Capital Management 12.34M $1.54B March 31, 2015
FMR 11.88M $1.48B March 31, 2015
Vanguard 10.02M $1.25B March 31, 2015
T. Rowe Price Associates 8.17M $1.02B March 31, 2015
PRIMECAP Management Company 8.03M $1.00B March 31, 2015
Columbia Wanger Asset Management 5.67M $279.40M Dec. 31, 2012
Jennison Associates 5.52M $688.02M March 31, 2015
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
Baker Bros. Advisors 4.20M $523.46M March 31, 2015
Inves 3.96M $156.73M June 30, 2012
STATE STREET CORPORATION 3.96M $285.63M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 3.78M $471.07M March 31, 2015
Capital World Investors^ 3.68M $205.21M June 30, 2013
Altrinsic Global Advisors 3.59M $144.55M Sept. 30, 2012
BlackRock Fund Advisors 3.38M $421.68M March 31, 2015

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company March 31, 2014 3.47M $260.08M
Cramer Rosenthal McGlynn Sept. 30, 2011 3.92M $125.08M
Sectoral Asset Management Sept. 30, 2011 3.54M $112.96M
Munder Capital Management Dec. 31, 2010 3.95M $105.90M
OrbiMed Advisors Dec. 31, 2010 3.41M $91.82M